Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
Keywords: addiction and substance use disorder; cannabidiol (CBD); cannabinoid (CB) receptors; genetics; laboratory model; magnetic resonance imaging (MRI); perinatal and neurodevelopmental abnormalities; psychosis and depressive disorder.
Conflict of interest statement
MC has been a consultant/advisor to GW Pharma Limited and F. Hoffmann-La Roche Limited, outside of this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.